Develops AI-powered cell-based blood tests to predict and prioritise organ transplant outcomes.
| Date | Round | Amount |
|---|---|---|
| Jul 2025 | Seed Plexision received $765K from the Richard King Mellon Foundation and Innovation Works to advance its AI precision-medicine transplant diagnostics. | $765K |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.